Nurix Therapeutics Files 8-K
Ticker: NRIX · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1549595
Sentiment: neutral
Topics: corporate-disclosure, regulatory-filing
Related Tickers: NRIX
TL;DR
Nurix filed an 8-K on 6/12/25, check it for Reg FD, other events, and financials.
AI Summary
Nurix Therapeutics, Inc. filed an 8-K on June 12, 2025, reporting on events including a Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 1700 Owens Street, Suite 205, San Francisco, CA 94158, and its primary business in Pharmaceutical Preparations.
Why It Matters
This 8-K filing provides an update on Nurix Therapeutics' corporate activities and regulatory disclosures, which is important for investors to monitor the company's compliance and operational status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant negative or positive news that would immediately impact risk.
Key Players & Entities
- Nurix Therapeutics, Inc. (company) — Registrant
- June 12, 2025 (date) — Date of Report
- 1700 Owens Street, Suite 205 (address) — Principal Executive Offices
- San Francisco, California (location) — City, State of Principal Executive Offices
- 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific events are being disclosed in this 8-K filing by Nurix Therapeutics?
The filing indicates disclosures related to Regulation FD, Other Events, and Financial Statements and Exhibits.
When was this 8-K report filed by Nurix Therapeutics?
The report was filed on June 12, 2025.
Where are Nurix Therapeutics' principal executive offices located?
The principal executive offices are located at 1700 Owens Street, Suite 205, San Francisco, California 94158.
What is Nurix Therapeutics' Standard Industrial Classification (SIC) code?
Nurix Therapeutics' SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the Commission File Number for Nurix Therapeutics?
The Commission File Number for Nurix Therapeutics is 001-39398.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Nurix Therapeutics, Inc. (NRIX).